African Journal of Infectious Diseases Research

ISSN 2756-3340

African Journal of Infectious Diseases Research | Vol. 12, No. 5, May 2025 | pp. 122–132

DOI: 10.46882/AJIDR/148761

Article Type: Research Article

Title: Molecular epidemiology and macrolide resistance mutations in Mycoplasma pneumoniae causing community-acquired pneumonia

Names of Authors: Kemi Adeyinka¹*, Jin-Soo Kim², Alejandro Vargas³

Authors’ Affiliations: ¹Department of Medical Microbiology, University of Ilorin, Ilorin, Nigeria. ²Department of Pediatrics, Seoul National University, Seoul, South Korea. ³Department of Pulmonology, Pontifical Catholic University of Chile, Santiago, Chile.

Abstract: Macrolide-resistant Mycoplasma pneumoniae poses a growing clinical challenge in the management of pediatric and adult community-acquired pneumonia. We investigated the prevalence of 23S rRNA domain V point mutations and P1 adhesin genotypes among respiratory isolates. Throat swabs from 310 patients with atypical pneumonia were screened using real-time polymerase chain reaction and Sanger sequencing. Mycoplasma pneumoniae was detected in 21.3 percent of cases, with the A2063G transition mutation identified in 68.2 percent of positive specimens. Patients infected with macrolide-resistant strains experienced significantly longer fever duration following initial azithromycin therapy. Surveillance of resistance mutations and timely consideration of alternative tetracyclines or fluoroquinolones are recommended.

Keywords: Mycoplasma pneumoniae, Macrolide resistance, Community-acquired pneumonia, Point mutations, Molecular epidemiology

Citation: Adeyinka K, Kim JS, Vargas A (2025). Molecular epidemiology and macrolide resistance mutations in Mycoplasma pneumoniae causing community-acquired pneumonia. African Journal of Infectious Diseases Research, 12(5): 122–132. DOI: 10.46882/AJIDR/148761

Manuscript Timeline: Received: March 14, 2025; Revised: April 16, 2025; Accepted: May 01, 2025; Published: May 07, 2025